Share on LinkedInShare on LinkedIn

ARTICLE · 08 MARCH 2007

"About" Doesn´t Get Around Limitations Imposed By Intrinsic Evidence

The U.S. Court of Appeals for the Federal Circuit recently affirmed a district court’s grant of summary judgment of non-infringement based on a claim interpretation of "about" in reference to a numerical ratio. Ortho-McNeil Pharm. Inc. v. Caraco Pharm. Labs., Ltd., Case No. 06-1102 (Fed. Cir., Jan. 19, 2007) (McKinney, C.J. of S.D. Ind., by designation).

United StatesIntellectual Property

The U.S. Court of Appeals for the Federal Circuit recently affirmed a district court’s grant of summary judgment of non-infringement based on a claim interpretation of "about" in reference to a numerical ratio. Ortho-McNeil Pharm. Inc. v. Caraco Pharm. Labs., Ltd., Case No. 06-1102 (Fed. Cir., Jan. 19, 2007) (McKinney, C.J. of S.D. Ind., by designation).

Ortho-McNeil Pharmaceutical, Inc. owns a patent that relates to a pharmaceutical composition comprising certain weight ratios of the analgesics tramadol and acetaminophen marketed as Ultracet®. Ortho filed suit after Caraco filed an Abbreviated New Drug Application (ANDA) for a generic version of Ultracet®, which included a paragraph IV certification with respect to the Ortho patent. Caraco’s ANDA requested approval for a formulation containing tramadol and acetaminophen with an average weight ratio of tramadol to acetaminophen of 1:8.67 and requiring a weight ratio of no less than 1:7.5. Ortho alleged that Caraco’s proposed

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from